Business Context and Reporting Period
Company: Nature's Sunshine Products, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2005
Business Overview: The Company operates in three segments: Nature's Sunshine Products (United States and International) and Synergy Worldwide. It markets health and wellness products through a direct sales force of independent distributors and managers.
Material Disclosure Note: The Company is currently reviewing selected financial information regarding certain foreign operations. Consequently, the independent auditor has not reviewed the accompanying unaudited consolidated financial statements. The Company intends to file an amendment to this report upon completion of the review. Additionally, the Company received notice from NASDAQ regarding potential delisting due to the delayed filing of this report and intends to appeal.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Sep 30, 2005 |
Nine Months Ended Sep 30, 2005 |
|---|---|---|
| Net Sales Revenue | $87,706 | $261,147 |
| Operating Income | $4,641 | $14,959 |
| Net Income | $4,325 | $12,360 |
| Diluted EPS | $0.28 | $0.80 |
| Cash and Cash Equivalents | $41,075 | $41,075 (Ending Balance) |
| Net Cash Provided by Operating Activities | N/A | $12,389 |
| Line of Credit Outstanding | $9,000 | $9,000 |
| Total Assets | $154,807 | $154,807 |
Margins (Nine Months 2005): Operating margin was 5.7%; Net income margin was 4.7%. Cost of goods sold was 17.7% of net sales.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 3.8% for the quarter and 7.6% for the nine-month period compared to the prior year. Growth was driven by the United States (up 10.5% QoQ) and International segments (up 13.4% QoQ), partially offset by a decline in the Synergy Worldwide segment.
- Profitability Decline: Operating income decreased 31.6% for the quarter and 1.3% for the nine-month period. Net income decreased 6.1% for the quarter and 0.5% for the nine-month period.
- Expense Increases: Selling, general, and administrative (SG&A) expenses rose 10.8% for the quarter, primarily due to expansion costs in Japan (Synergy Worldwide) and the Russian Federation. Volume incentives increased 3.6% for the quarter.
- Tax Provision: The provision for income taxes dropped significantly (96.9% decrease for the quarter) due to the resolution of certain income tax contingencies resulting in a benefit.
- Segment Performance: The Synergy Worldwide segment reported an operating loss of $0.98 million for the quarter, compared to an operating income of $1.88 million in the prior year, attributed to launch costs in Japan and losses in Thailand.
Guidance, Outlook, and Risks
- Outlook: Management expects cost of goods sold to increase slightly as a percentage of sales for the remainder of 2005. SG&A expenses as a percentage of sales are expected to decrease due to cost controls and continued revenue growth. The effective income tax rate is expected to increase for the balance of the year.
- Stock Repurchase: The Company completed a Dutch Auction tender offer, repurchasing 513,006 shares at $21.75 per share for a total of approximately $11.3 million. No further repurchase program is currently in place.
- Liquidity: The Company maintains a $15 million unsecured line of credit with $9 million outstanding. Management believes working capital requirements can be met through cash, operating activities, and the line of credit.
- Risks and Contingencies:
- Financial Review: Ongoing review of foreign operations may result in material changes to financial statements.
- Delisting Risk: Potential delisting from NASDAQ due to late filing; appeal is pending.
- Product Liability: The Company self-insures for product liability and cannot obtain insurance for products containing ephedrine alkaloids and kava. Actual liabilities could exceed recorded estimates.
- Foreign Currency: Approximately 57.4% of revenue is realized outside the U.S. A strengthening U.S. dollar negatively impacts operating results.
Investor Verification Checklist
- Verify the outcome of the independent auditor's review of foreign operations and any subsequent amendments to the 10-Q.
- Monitor the status of the NASDAQ delisting appeal and the Company's compliance with listing standards.
- Assess the sustainability of the Synergy Worldwide segment's losses and the timeline for profitability in Japan and Thailand.
- Review the adequacy of self-insurance reserves for product liability claims, particularly regarding regulatory scrutiny of specific ingredients.
- Confirm the impact of the resolved income tax contingencies on future effective tax rates.